Related Experiment Video
Updated: May 2, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
An update on occupation and prostate cancer
Glenn Doolan1, Geza Benke, Graham Giles
1Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Occupational exposure to toxic metals, polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons (PAHs) is linked to prostate cancer risk. Further research is needed to identify specific pesticides associated with this cancer.
Area of Science:
- Occupational health
- Epidemiology
- Environmental science
Background:
- Literature review to identify research gaps in occupational prostate cancer risk.
- Focus on chemical, ergonomic, physical, environmental, and psychosocial exposures.
- Recommendations for future research directions.
Purpose of the Study:
- To review occupational exposures and related factors associated with prostate cancer risk.
- To identify gaps and limitations in current scientific literature.
- To provide recommendations for future research.
Main Methods:
- Systematic review of epidemiological studies published between 2000 and 2012.
- Analysis of occupational exposures including chemical, ergonomic, physical, environmental, and psychosocial factors.
- Evaluation of study limitations such as retrospectivity and exposure assessment bias.
Main Results:
- Inconsistent results across studies, often due to reliance on retrospective and ecological designs.
- Exposure assessment bias is a common limitation in reviewed studies.
- Sufficient evidence links toxic metals, PCBs, and PAHs to prostate cancer risk.
Conclusions:
- Insufficient evidence implicates ergonomic, physical, environmental, or psychosocial factors in prostate cancer risk.
- Sufficient evidence links toxic metals, polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons (PAHs) to prostate cancer.
- Further research is necessary to identify specific pesticides associated with prostate cancer risk.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression

